Related references
Note: Only part of the references are listed.Editorial: Adaptive Designs: Appealing in Development of Therapeutics, and Where do Controversies Lie?
Sue-Jane Wang
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2010)
Stochastic Approximation and Modern Model-Based Designs for Dose-Finding Clinical Trials
Ying Kuen Cheung
STATISTICAL SCIENCE (2010)
High-Dose Lovastatin for Acute Ischemic Stroke: Results of the Phase I Dose Escalation Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)
Mitchell S. V. Elkind et al.
CEREBROVASCULAR DISEASES (2009)
Adaptive designs for confirmatory clinical trials
Frank Bretz et al.
STATISTICS IN MEDICINE (2009)
The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke
Mitchell S. V. Elkind et al.
INTERNATIONAL JOURNAL OF STROKE (2008)
Simple sequential boundaries for treatment selection in multi-armed randomized clinical trials with a control
Ying Kuen Cheung
BIOMETRICS (2008)
Proof-of-principle phase II MRI studies in stroke -: Sample size estimates from dichotomous and continuous data
Geoffrey A. Donnan et al.
STROKE (2006)
Adaptive designs in clinical drug development - An Executive Summary of the PhRMA Working Group
Paul Gallo et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2006)
Controlling test size while gaining the benefits of an internal pilot design
CS Coffey et al.
BIOMETRICS (2001)
Sequential designs for phase I clinical trials with late-onset toxicities
YK Cheung et al.
BIOMETRICS (2000)